Thyrotropic hormone: important influencing factors to consider. Part 2

Main Article Content

O.V. Rykova


Thyroid pathology is one of the most common endocrinopathies, and it is the endocrinologist who diagnoses and determines the treatment. But it is characterized by a wide variety of clinical manifestations requiring specific treatment without which it is impossible to achieve the efficacy. For them, the patient addresses to other specialists in the first stage. This necessitates the exclusion of endocrinopathy by doctors of diffe­rent specialties: cardiologists, gynecologists, neurologists, family doctors and others, that is, the timely inclusion of thyrotropic hormone (TTH) evaluation, recognized in the world as screening test, into the algorithm for examining patients or referring a patient to endocrinologist. On the basis of TTH levels, further patient’s examination is determined. Today, sometimes situations occur when a patient is examined in different laboratories, and the results obtained, which determine the hormonal status of a patient, are slightly different. What are the possible causes of discordant results? What to consider? What factors should be taken into account when evaluating TTH levels and du­ring interpretation? Interpretation algorithms: benchmarks or diagnostic thresholds? Why do the laboratory results of TTH determination indicate that treatment is ineffective against the background of sufficient dosage and adherence? We will look at the answers to these questions in this article in terms of some factors that influence TTH levels.

Article Details

How to Cite
Rykova, O. “Thyrotropic Hormone: Important Influencing Factors to Consider. Part 2”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 15, no. 8, Sept. 2021, pp. 639-43, doi:10.22141/2224-0721.15.8.2019.191688.
Methodical Recomendations


Mirjanic-Azaric B, Stojakovic-Jelisavac T, Vukovic B, Stojanovic D, Vujnic M, Uletilovic S. The impact of time of sample collection on the measurement of thyroid stimulating hormone values in the serum. Clin Biochem. 2015 Dec;48(18):1347-9. doi: 10.1016/j.clinbiochem.2015.08.020.

Sviridonova MA, Fadeyev VV, Sych YP, Melnichenko GA. Clinical significance of TSH circadian variability in patients with hypothyroidism. Endocr Res. 2013;38(1):24-31. doi: 10.3109/07435800.2012.710696.

Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14;291(2):228-38. doi: 10.1001/jama.291.2.228.

Karmisholt J, Andersen S, Laurberg P. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur J Endocrinol. 2011 Mar;164(3):317-23. doi: 10.1530/EJE-10-1021.

Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017 Mar;27(3):315-389. doi: 10.1089/thy.2016.0457.

Wiersinga WM. Hypothyroidism and Myxedema Coma. In: Jameson JL, de Groot LJ, Grossman AB, et al. Endocrinology: Adult and Pediatric. 7th ed. Vol 2. Philafelphia, PA: Elsevier Saunders; 2016. 1540-1556.e4 pp. doi: 10.1016/B978-0-323-18907-1.00088-3.

Callejas L, Mallesara S, Orlander P. Iodine Intake and Healthy Aging. In: Malavolta M, Mocchegiani E, editors. Molecular Basis of Nutrition and Aging. Philafelphia, PA: Elsevier Academic Press; 2016. 583-597 pp. doi: 10.1016/C2014-0-00388-7.

Most read articles by the same author(s)